Tacrolimus IR Pellets 0.5%, 1%, 5% – Suitable for Capsules (Dose: 0.5 mg, 1 mg, 5 mg)

  • Tacrolimus is a potent immune suppressant. Tacrolimus is the first of the LIMUS based immunosuppressant to be marketed as a solid dosage capsule, infusion and ointment.
  • Murli Krishna Pharma’s technology addresses all the three formulations of Tacrolimus.
  • We do offer development services in case of a requirement for different formulation/dosage/strength
  • Offer complete technical package for registrations in all regulated/semi regulated markets
  • Products protected by ongoing Patents are not offered by MKPPL.


Share
Additional information
Percentage

0.5%, 1.0%, 5.0%

Mesh Size

16# 20, 35#50, 50#70

Quality Standard

USP43

Documentation Available:

DMF in CTD Format

Release Type

Immediate Release

Forms of PFI

Pellets/Micro pellets (for capsules)

Target Formulations

Capsules

The information presented on this web site does not constitute an offer for sale in territories where it is not permitted by Patent Law.

Selected Brand - Globe Platinum Awards 2016
Excellence in CSR & Sustainability

Privacy Preference Center